Cite
MLA Citation
Gregory Guzauskas et al.. “HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE.” Neuro-oncology, vol. 20, n.d., pp. vi116–vi117. http://access.bl.uk/ark:/81055/vdc_100095483760.0x000015